Corporate news

Grifols Los Angeles site is awarded "Highly Protected Risk (HPR)" status The HPR award recognizes the highest level asite can achieve in terms of prevention and protection
+ info

Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia Three-year commitment of up to 20 million units per year of blood clotting medicines to treat hemophilia patients in developing countries
+ info

Grifols opens new plasma fractionation plant in Spain The company has invested over 20 million euros, doubling its plasma fractionation capacity in Spain
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

banner a awards Martín VillarMartín Villar Haemostasis Awards

Grifols is holding the seventh edition of the Martin Villar Awards for Research in Haemostasis. + info


get to know us better

2012 Awards Martí Villar